|
|
|
Insider
Information: |
Ketchum Steven B |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
755,099 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$409,880 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
755,099 |
|
|
Total
Value |
$409,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2015-07-24 |
84,259 |
2010-06-30 |
0 |
Premium* |
|
Amarin Corp Plc |
AMRN |
|
2024-07-31 |
670,840 |
2015-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
134 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,884 |
520,796 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-12-30 |
4 |
D |
$1.21 |
$19,797 |
D/D |
(16,361) |
544,021 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,767 |
560,382 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-01-31 |
4 |
D |
$1.86 |
$25,493 |
D/D |
(13,706) |
564,882 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,567 |
578,588 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-02-21 |
4 |
D |
$1.80 |
$26,136 |
D/D |
(14,520) |
579,496 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
29,134 |
594,016 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,333 |
595,829 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-02-28 |
4 |
D |
$2.03 |
$15,668 |
D/D |
(7,718) |
588,111 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-07-31 |
4 |
D |
$1.19 |
$13,998 |
D/D |
(11,763) |
600,231 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,883 |
611,994 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-12-12 |
4 |
AS |
$0.79 |
$26,963 |
D/D |
(34,131) |
566,100 |
0 |
% |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,766 |
613,866 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-12-29 |
4 |
A |
$0.87 |
$20,467 |
D/D |
23,525 |
590,341 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-04 |
4 |
D |
$0.87 |
$6,725 |
D/D |
(7,730) |
597,177 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,566 |
604,907 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-10 |
4 |
D |
$0.97 |
$27,422 |
D/D |
(28,270) |
620,407 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,500 |
648,677 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
79,500 |
681,036 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-01-31 |
4 |
D |
$1.24 |
$51,072 |
D/D |
(41,187) |
658,720 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-07-31 |
4 |
D |
$0.78 |
$9,175 |
D/D |
(11,763) |
670,840 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2024-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,883 |
682,603 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
|
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
99,940 |
340,535 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
|
2010-06-30 |
4 |
B |
$0.28 |
$65,517 |
D/D |
238,243 |
240,595 |
2.74 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
|
2010-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
38,969 |
379,504 |
0 |
- |
|
134 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|